Introduction
============

Liver cirrhosis is the final stage of a chronic fibrotic process in the liver and is the primary cause of portal hypertension. Hyperdynamic circulation, which is secondary to the presence of systemic vasodilation, is an important factor in the aggravation and persistence of portal hypertension ([@b1-etm-0-0-2823]). Numerous mechanisms are involved in the development of systemic vasodilation, including increased synthesis of nitric oxide (NO) and carbon monoxide (CO) and the activation of K~ATP~ channels in the systemic and splanchnic arterial circulation ([@b2-etm-0-0-2823]). Previous studies have demonstrated that the hepatic heme oxygenase-1 (HO-1)/CO system ([@b3-etm-0-0-2823]) and NO/nitric oxide synthetase activity are overexpressed in rats with cirrhosis and contribute to portal hypertension ([@b4-etm-0-0-2823])

In a previous study, hydrogen sulfide (H~2~S) was identified as the third endogenous signaling gasotransmitter, in addition to NO and CO, and was found to serve crucial functions in normal physiological conditions and in the process/progress of numerous diseases ([@b5-etm-0-0-2823]). H~2~S is produced endogenously from cysteine by pyridoxal-5-phosphate-dependent enzymes, including cystathionine-β-synthase and cystathionine-γ-lyase (CSE) ([@b6-etm-0-0-2823]), and is involved in vasorelaxation by activating the K~ATP~ channel, a different mechanism from that of NO and CO ([@b7-etm-0-0-2823],[@b8-etm-0-0-2823]).

NO is endogenously generated by vascular endothelial cells, while H~2~S is derived from vascular smooth muscle cells and CO is endogenously produced by vascular endothelial and smooth muscle cells; therefore, it is plausible that these gaseous transmitters may interact in the regulation of biological functions ([@b9-etm-0-0-2823]--[@b12-etm-0-0-2823]). It has previously been shown that NO is able to upregulate the endogenous production of H~2~S by increasing CSE gene expression ([@b8-etm-0-0-2823]). Additionally, H~2~S is able to enhance vasodilation by NO at very low concentrations ([@b8-etm-0-0-2823]).

The effect of CO on the production of H~2~S remains unclear. CSE is the primary enzyme involved in catalyzing the endogenous production of H~2~S in mammalian hepatic tissue ([@b13-etm-0-0-2823]), and \>50% of the gas in the liver appears to be derived from CSE ([@b13-etm-0-0-2823]). The aim of the present study was to investigate the effect of endogenous CO on the H~2~S/CSE pathway in cirrhotic livers of rats by manipulating HO-1 enzyme activity via the intraperitoneal injection of zinc protoporphyrin IX (ZnPP), a specific HO-1 enzyme inhibitor, or cobalt protoporphyrin (CoPP), a specific HO-1 enzyme inducer.

Materials and methods
=====================

### Animal care

The experimental protocols were approved by the Animal Care and Use Committee of Dalian Medical University (Dalian, China), in accordance with the guidelines established by the Canadian Council on Animal Care. A total of 45 healthy male Sprague Dawley rats (weight, 200--220 g; age, 6 weeks) were obtained from the Animal Center of Dalian Medical University (Dalian, China).

### Reagents

TRIzol® reagent was obtained from Nanjing KeyGen Biotech, Co., Ltd. (KGA1203; Nanjing, China); a PrimeScript® RT Master Mix Perfect Real Time kit (DRR036A) and SYBR® Premix Ex Taq™ (DRR420A) were purchased from Takara Biotechnology Co., Ltd. (DRR036A; Dalian, China); polyclonal rabbit anti-mouse HO-1 and rabbit anti-mouse CSE antibodies were obtained from Wuhan Boster Biological Technology Co., Ltd. (Wuhan, China); anti-rabbit IgG was obtained from Fuzhou Maixin Biotechnology Development Co., Ltd. (MaxVision™2; Fuzhou, China); a Takara RNA polymerase chain reaction (PCR) kit (alfalfa mosaic virus) Ver. 3.0 was purchased from Takara Biotechnology Co., Ltd.; and CoPP and ZnPP were obtained from Sigma-Aldrich (St. Louis, MO, USA).

### Animal model and grouping

Rats were randomly divided into four groups: Sham (n=8), cirrhosis (n=8), CoPP (n=12) and ZnPP (n=12). The rats were housed in a specific pathogen-free center, at a temperature of 24--26°C and at a relative humidity of 60--65%. Rats were housed for 3 days prior to experimental protocols being initiated, were well fed and received water *ad libitum*. Bile duct ligation (BDL) was used to induce cirrhosis in rats in the cirrhosis, CoPP and ZnPP groups, according to the method described in a previous study ([@b14-etm-0-0-2823]). Laparotomy was performed under anesthesia with ether. The bile duct was isolated and double ligated with 3-0 silk. The abdominal wall and the skin were closed with 4-0 silk sutures, and antibiotic benzathine benzylpenicillin powder was sprinkled over the closed incision. The rats were continuously fed and housed for an additional 4-week period after surgery, and samples were collected. Rats in the sham group underwent laparotomy, with the bile duct isolated but not ligated. ZnPP and CoPP (Sigma-Aldrich) were dissolved in 0.2 mol/l NaOH, adjusted to pH 7.4 and diluted in 0.85% NaCl. The final concentration was 1 mg/ml, as previously described ([@b15-etm-0-0-2823]), and the resulting ZnPP and CoPP solutions were used to inhibit or induce HO-1 expression, respectively. Rats in the ZnPP and CoPP groups received an intraperitoneal injection of ZnPP or CoPP (5 mg/kg/day), respectively, for a week prior to sample collection. In addition, 5 of the initial 45 rats died prior to sample collection.

### Sample collection

At 4 weeks after surgery, the rats were anesthetized with ether and the portal vein was isolated. A catheter, connected to pressure transducers (BL-420F data acquisition and analysis system; Chengdu Technology & Market Co., Ltd., Chengdu, China), was placed in the portal vein to measure portal vein pressure (PVP). Arterial blood (1 ml) was then collected using a heparinized syringe through the arterial catheter to measure carboxyhemoglobin (COHb) levels using a RapidLab 1245 blood gas analyzer (Siemens Healthcare, Malvern, PA, USA) as an index for the CO level in arterial blood. Subsequently, 4 ml portal venous blood was collected from the rats to measure serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total bilirubin (TBIL) using a Hitachi 7600-110 automatic biochemical analyzer (Hitachi, Ltd., Tokyo, Japan). One lobe of the liver was excised and tissue samples were fixed in 10% neutral formalin solution and embedded in paraffin; the remaining tissue was preserved at −80°C for subsequent quantitative PCR (qPCR) analysis.

### Measurement of serum H2S

Plasma samples (75 µl) were mixed with 100 µl distilled water and 300 µl 10% trichloroacetic acid. Then, 150 µl 1% zinc acetate was added to Eppendorf tubes, along with 20 µM *N,N*-Dimethyl-*p*-phenylenediamine sulfate in 7.2 M HCl and FeCl~3~ (30 µM; 133 µl) in 1.2 M HCl. After 15 min of incubation, the absorbance of the solution was measured at a wavelength of 670 nm using a UV-2550 spectrophotometer (Shimadzu Corp., Kyoto, Japan). All samples were assayed in duplicate, and the H~2~S concentration was calculated against a calibration curve of NaHS (0.122--250 µM).

### Hepatic hydroxyproline (HYP) content

The HYP content in the liver was evaluated as an indirect index of tissue collagen content, according to a previously described method with modification ([@b16-etm-0-0-2823]), and was expressed in micrograms per gram of wet weight (µg/g).

### Pathological analysis

Hematoxylin and eosin (H&E) staining was performed according to standard procedures. The changes in liver cells, portal areas and central veins were assessed. In addition, Van Gieson\'s staining was conducted to visualize collagen type I. Sections were stained with Weigerts Resorcin Fuchsin at room temperature for 25 min, washed with water, differentiated in acid alcohol, then washed in water for a further 10 min. The sections were subsequently stained with Van Gieson for 5 min, washed in water, dehydrated with ethanol, cleared using xylene and mounted for observation.

### Immunohistochemical analysis

Liver tissues were fixed in a 10% neutral formalin solution, embedded in paraffin wax and cut into sections of 1 × 0.8 × 0.0004 cm. Certain sections were stained with H&E, while others underwent deparaffinization, rehydration and inactivation, prior to being incubated with rabbit-anti-mouse CSE and HO-1 polyclonal antibodies (1:50) at room temperature for 60 min. Following incubation with the primary antibody, the sections were incubated with a secondary antibody (MaxVision 2) at room temperature for 15 min. The sections were protected by coverslips following staining. The primary antibody was replaced by phosphate-buffered saline to serve as a negative control. Samples were incubated with 3% H~2~O~2~ for 10 min at room temperature to eliminate endogenous peroxidase activity and to block nonspecific background staining. Subsequently, the sections were washed with distilled water, 0.01 M citrate buffer (pH=6.0) was added and the sections were heated by microwave oven for 10 min. Following cooling, the sections were washed with 0.1 M PBS wash buffer 3 times. The immunoreactive signal was visualized by color deposition, using diaminobenzidine as a substrate. Yellow material in the cytoplasm was considered to indicate positive cells. Images were analyzed using Image-Pro Plus software, version 6.0 (Media Cybernetics, Inc., Rockville, MD, USA) to calculate the area and mean density of positive expression. Mean density was calculated as follows: Integrated optical density/area of interest. Results from five visual fields were averaged for each sample.

### qPCR analysis

Quantification of the expression level of target genes was performed using qPCR. Total RNA was extracted from rat livers using TRIzol reagent (Nanjing KeyGen Biotech. Co., Ltd.). After extraction of RNA, reverse transcription was performed using random primers provided with the Takara PCR kit, following the manufacturer\'s instructions. The PCR amplification conditions were as follows: Pre-denaturation at 95°C for 30 sec, followed by 40 cycles of amplification by denaturing at 95°C for 5 sec, annealing at 60°C for 1 min and extending at 72°C for 30 sec. PCR cycling was performed using a Mx3005P qPCR system (Agilent Technologies, Inc., Santa Clara, CA, USA). The relative quantity of mRNA for each gene was normalized against the quantity of the housekeeping gene β-actin. Each sample was run and analyzed in triplicate. The primer sequences for CSE were as follows: 5′-GAG CCG GAG CAA TGG AGT TC-3′ (forward) and 5′-GGA TTT CCA GAG CGG CTG TA-3′ (reverse). The primer sequences for β-actin were: 5′-GGA GAT TAC TGC CCT GGC TCC TA-3′ (forward) and 5′-GAC TCA TCG TAC TCC TGC TTG CTG-3′ (reverse). The primers were designed and synthesized by Takara Biotechnology Co., Ltd.

### Statistical analysis

Data analysis was performed using SPSS software, version 10.0 (SPSS, Inc., Chicago, IL, USA). Analysis of variance or Wilcoxon statistical methods were used to determine statistical differences. All data are expressed as the mean ± standard deviation. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Biochemical examination

At 4 weeks after surgery, ascites and jaundice were observed in the groups subjected to BDL, indicating that the BDL model was successfully established.

The serum levels of AST, ALT and TBIL in the cirrhosis group were significantly higher than those in the sham group (P\<0.05). Furthermore, the levels were higher in the CoPP group and reduced in the ZnPP group compared with those in the cirrhosis group (P\<0.05) ([Table I](#tI-etm-0-0-2823){ref-type="table"}). The serum levels of H~2~S in the cirrhosis group were significantly lower than those in the sham group (P\<0.05). Furthermore, serum H~2~S was higher in the ZnPP group and lower in the CoPP group compared with that in the cirrhosis group (P\<0.05). The levels of COHb in the arterial blood were significantly higher in the cirrhosis group than those in the sham group (P\<0.05). Compared with the cirrhosis group, the COHb levels were significantly decreased in the ZnPP group (P\<0.05) and significantly increased in the CoPP group (P\<0.05). The PVP was significantly higher in the cirrhosis group than that in the sham group (P\<0.05). Compared with the cirrhosis group, the PVP was significantly higher in the CoPP group and reduced in the ZnPP group (P\<0.05) ([Table II](#tII-etm-0-0-2823){ref-type="table"}).

### Histopathological analysis of the liver

The degree of hepatic fibrosis was evaluated by H&E staining. The sham group exhibited normal hepatic architecture, whereas the cirrhosis group exhibited the histological characteristics of bile duct proliferation and extensive fibrosis. Compared with the cirrhosis group, fibrous hyperplasia and fibrotic extensions with fibroblast proliferation were less prevalent in the ZnPP group and more prominent in the CoPP group ([Fig. 1](#f1-etm-0-0-2823){ref-type="fig"}).

Collagen type I was observed using Van Gieson\'s staining ([Fig. 2](#f2-etm-0-0-2823){ref-type="fig"}). In the cirrhosis group, collagen type I in the portal area and bile duct wall was markedly thicker than that in the sham group (P\<0.01). Compared with the cirrhosis group, the extent of fibrosis was increased in the CoPP group and decreased in the ZnPP group. The change in HYP content in the liver tissue was in accordance with the change in type I collagen. Compared with the sham group, the HYP content was higher in the cirrhosis group. Compared with the cirrhosis group, the HYP content was higher in the CoPP group and lower in the ZnPP group (P\<0.05).

### Immunohistochemical detection of CSE and HO-1 protein expression levels

To localize the CSE and HO-1 protein expression levels in the livers, immunohistochemical analysis was conducted using specimens from the four groups. As shown in [Fig. 3](#f3-etm-0-0-2823){ref-type="fig"}, the expression of the HO-1 protein was primarily located in Kupffer\'s cells and hepatocytes, which is consistent with the observations of previous studies ([@b17-etm-0-0-2823],[@b18-etm-0-0-2823]). In addition, the intensity and percentage of cells expressing HO-1 protein in the liver were detected. Mild staining was observed in hepatic tissue samples from the sham group, with a score of 0.63±0.51. The HO-1 immunoreactivity was strongly positive in the cirrhosis group with a score of 4.63±0.72, which was significantly higher than that in the sham group (P\<0.01). Compared with the cirrhosis group, the HO-1 score was increased in the CoPP group (6.21±0.85) and decreased in the ZnPP group (2.98±0.68) (both P\<0.05). The expression of the CSE protein was predominantly located in hepatocytes and hepatic stellate cells (HSCs) ([Fig. 4](#f4-etm-0-0-2823){ref-type="fig"}), which is consistent with previous studies ([@b5-etm-0-0-2823],[@b19-etm-0-0-2823]). The intensity and percentage of cells expressing hepatic CSE protein were additionally evaluated. There was moderate positive staining in the sham group, with an overall score of 1.21±0.33. The CSE score in the cirrhosis group was 0.79±0.25, which was significantly reduced compared with that in the sham group (P\<0.01). Compared with the cirrhosis group, the CSE score was further decreased in the CoPP group (0.21±0.18), whereas it was increased in the ZnPP group (1.16±0.46) (both P\<0.05).

### Hepatic CSE mRNA expression levels

As determined by qPCR, the hepatic expression levels of CSE mRNA in the cirrhosis group were significantly lower than those in the sham group (P\<0.01). Furthermore, compared with the cirrhosis group, hepatic CSE mRNA expression levels were significantly decreased in the CoPP group, but significantly increased in the ZnPP group (P\<0.05) ([Fig. 5](#f5-etm-0-0-2823){ref-type="fig"}).

Discussion
==========

Hyperdynamic circulation is a key characteristic of cirrhosis-induced portal hypertension, which is secondary to the presence of systemic vasodilation. Numerous hypotheses have been postulated regarding the development of systemic vasodilation, including increased synthesis of NO and CO and the activation of K~ATP~ channels in vascular smooth cells in the systemic and splanchnic arterial circulation ([@b4-etm-0-0-2823],[@b20-etm-0-0-2823],[@b21-etm-0-0-2823]). H~2~S has been presented as a third endogenous signaling gasotransmitter, with similar properties to those of NO and CO. H~2~S is a crucial vasodilator in the hepatic microcirculation and causes relaxation of vascular smooth muscle ([@b22-etm-0-0-2823]). H~2~S is produced endogenously from cysteine by pyridoxal-5′-phosphate-dependent enzymes, including cystathionine-β-synthase and CSE ([@b6-etm-0-0-2823],[@b23-etm-0-0-2823]), and induces vasorelaxation via the activation of ATP-sensitive K^+^ channels in vascular smooth muscle ([@b24-etm-0-0-2823]). This mechanism of vasorelaxation induction differs from that of NO and CO ([@b7-etm-0-0-2823],[@b8-etm-0-0-2823]). CSE is the primary enzyme in mammalian hepatic tissue for catalyzing the endogenous production of H~2~S ([@b13-etm-0-0-2823],[@b19-etm-0-0-2823]), and \>50% of the volume of gas in the liver appears to be derived from CSE ([@b13-etm-0-0-2823],[@b19-etm-0-0-2823]). To the best of our knowledge, the present study is the first to investigate whether the H~2~S/CSE pathway is involved in the formation of liver cirrhosis.

The results of the present study demonstrated that serum levels of ALT, AST and TBIL were significantly higher in the cirrhosis group than those in the sham group, indicating that BDL caused marked liver injury. The presence of liver cirrhosis was confirmed by H&E staining in the livers of 4-week BDL rats. Additionally, the PVP was significantly higher in rats that underwent BDL compared with that in time-matched sham rats, indicating the presence of portal hypertension. These results suggested that the BDL model had been successfully established. The levels of H~2~S were significantly lower in the cirrhosis group than those in the sham group. Furthermore, CSE protein and mRNA levels were significantly lower in the cirrhosis group than those in the sham group. A recent study by Wang *et al* ([@b25-etm-0-0-2823]) generated a similar result; it was observed that rats with portal hypertension had lower endogenous H~2~S concentrations in comparison with healthy control rats and that the concentration was inversely associated with disease severity.

Previous studies have shown that H~2~S is endogenously generated by vascular smooth muscle cells, while CO is primarily formed in vascular smooth muscle cells and partially in vascular endothelial cells. These observations suggest that H~2~S and CO may interact in the regulation of biological functions ([@b26-etm-0-0-2823]--[@b28-etm-0-0-2823]); however, the interaction between the CO/HO and H~2~S/CSE pathways remains unclear. A secondary aim of the present study was to investigate the effect of endogenous CO on the H~2~S/CSE pathway in the livers of cirrhotic rats by manipulating HO-1 enzyme activity via an intraperitoneal injection of either ZnPP, a specific HO-1 enzyme inhibitor, or CoPP, a specific HO-1 enzyme inducer. The levels of COHb in the rat arterial blood were significantly higher in the cirrhosis group compared with those in the sham group, suggesting that overproduction of CO occurs in the rats with cirrhosis, as CO is predominately found bound to hemoglobin in the form of COHb in the circulation ([@b29-etm-0-0-2823]). Compared with the cirrhosis group, COHb levels were significantly lower in the ZnPP group and significantly higher in the CoPP group. HO-1 is the primary source of circulating CO ([@b30-etm-0-0-2823]), and the results of the present study showed that the levels of COHb were in accordance with HO-1 expression. Furthermore, the present results demonstrated that the serum levels of H~2~S were significantly higher in the ZnPP group and significantly lower in the CoPP group, compared with the levels observed in the rats in the cirrhosis group. In addition, in comparison with the cirrhosis group, CSE protein and mRNA expression levels were significantly higher in the ZnPP group and significantly lower in the CoPP group. Collectively, these results suggest that endogenous CO is able to downregulate hepatic CSE expression in the livers of rats with cirrhosis.

The serum levels of AST, ALT and TBIL in the CoPP group were significantly higher than those in the cirrhosis group. Furthermore, compared with the cirrhosis group, more fibrous hyperplasia and fibrotic extensions with fibroblast proliferation were observed in the CoPP group. These differences indicated that the liver damage was more severe in the CoPP group than that in the cirrhosis group. In contrast to the levels of liver damage, the production of H~2~S and hepatic CSE expression were reduced in the CoPP group compared with those in the cirrhosis group. The ZnPP group, however, exhibited decreased liver damage and increased H~2~S production and hepatic CSE expression compared with the cirrhosis group. These results suggest that H~2~S may serve a crucial function in protecting liver cells against the progression of liver fibrosis. Poliakova *et al* ([@b31-etm-0-0-2823]) observed that H~2~S was able to induce biochemical restructuring of the rat liver, with long-term exposure (\>2 weeks) to a low dose and short-term exposure to a high dose of an H~2~S-containing gaseous mixture both leading to reversible changes in the liver. A potential mechanism by which H~2~S inhibits liver fibrosis involves the induction of apoptosis ([@b32-etm-0-0-2823]) and inhibition of HSC activation ([@b22-etm-0-0-2823],[@b33-etm-0-0-2823]). In the present study, the increased severity of liver damage observed in the CoPP group may have been partially due to the lower production of H~2~S, as a result of inhibition by endogenous CO.

Although previous reports have indicated that HO-1 performs a protective function in various liver diseases ([@b34-etm-0-0-2823]) and that the upregulation of HO-1 prevents the progression of liver fibrosis in Mdr2-knockout mice ([@b35-etm-0-0-2823]), our previous study suggested that the overexpression of HO-1 is harmful to liver function and aggravates liver fibrosis in rats subjected to BDL ([@b36-etm-0-0-2823]). A potential reason underlying these conflicting results may be that HO-1 plays various roles in the progression of liver fibrosis ([@b37-etm-0-0-2823]), and the protection of HO-1 is restricted to a narrow threshold of expression ([@b38-etm-0-0-2823]). In the early stages of liver fibrosis, low HO-1 induction may be protective in liver cells ([@b39-etm-0-0-2823]); however, in the end stage of cirrhosis with portal hypertension, excessive HO-1 expression may deteriorate liver function and aggravate liver cirrhosis ([@b36-etm-0-0-2823]).

In conclusion, the present study indicates that vascular function cannot be independently regulated by a single molecule or its pathway ([@b40-etm-0-0-2823]). In addition to NO and CO, the H~2~S/CSE pathway is involved in the formation of liver cirrhosis, and H~2~S may be involved in protecting liver cells against the progression of liver fibrosis. Endogenous CO downregulated the mRNA and protein expression levels of hepatic CSE, in addition to the production of H~2~S in rats with liver cirrhosis. As CO and H~2~S are produced in vascular smooth muscle cells, and have comparable characteristics and biological function to vasodilation, the dynamic interplay between CO and H~2~S may have a significant role in the maintenance of homeostasis; however, the specific underlying mechanisms and interaction of these molecules with NO require further study.
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![Representative photomicrographs showing pathological changes in the liver. (A) Normal structure of the liver; (B) liver cirrhosis; (C and D) liver structure in the (C) CoPP and (D) ZnPP groups (hematoxylin and eosin staining; magnification, ×100). (E) Histopathological scores for fibrosis. Values are expressed as the mean ± standard deviation. ^a^P\<0.01 vs. sham group; ^b^P\<0.05 vs. cirrhosis group. CoPP, cobalt protoporphyrin; ZnPP, zinc protoporphyrin IX.](etm-10-06-2039-g00){#f1-etm-0-0-2823}

![Van Gieson\'s staining of collagen type I in liver sections and liver hydroxyproline content. (A) Collagen type I was barely detectable in the sham group, showed marked deposition in the (B) cirrhosis and (C) CoPP groups, and was less prevalent in the (D) ZnPP group (magnification, ×200). (E) Area of collagen type I. (F) Hydroxyproline content of liver tissue in different groups. Values are expressed as the mean ± standard deviation. ^a^P\<0.01 vs. sham group; ^b^P\<0.05 vs. cirrhosis group. CoPP, cobalt protoporphyrin; ZnPP, zinc protoporphyrin IX.](etm-10-06-2039-g01){#f2-etm-0-0-2823}

![Hepatic HO-1 protein expression. Immunohistochemical staining of hepatic HO-1 protein in rats in the (A) sham, (B) cirrhosis, (C) CoPP and (D) ZnPP groups (magnification, ×200). (E) Scores for the immunohistochemical staining of hepatic HO-1 protein expression in each group. (F) Levels of COHb were in accordance with HO-1 expression. Values are expressed as the mean ± standard deviation. ^a^P\<0.01 vs. sham group; ^b^P\<0.05 vs. cirrhosis group. HO-1, heme oxyenase-1; CoPP, cobalt protoporphyrin; ZnPP, zinc protoporphyrin IX; COHb, carboxyhemoglobin.](etm-10-06-2039-g02){#f3-etm-0-0-2823}

![Hepatic CSE protein expression. Immunohistochemical staining of hepatic CSE protein in rats in the (A) sham, (B) cirrhosis, (C) CoPP and (D) ZnPP groups (magnification, ×100). (E) Scores for the immunohistochemical staining of hepatic CSE protein expression in each group. ^a^P\<0.01 vs. sham group; ^b^P\<0.05 vs. cirrhosis group. CSE, cystathionine-γ-lyase; CoPP, cobalt protoporphyrin; ZnPP, zinc protoporphyrin IX.](etm-10-06-2039-g03){#f4-etm-0-0-2823}

![Hepatic CSE mRNA expression. Quantitative data showing the hepatic CSE mRNA expression levels. CSE mRNA levels were lower in the cirrhosis group than those in the sham group. Compared with the cirrhosis group, expression was significantly higher in the ZnPP group and lower in the CoPP group. ^a^P\<0.01 vs. sham group; ^b^P\<0.05 vs. cirrhosis group. CSE, cystathionine-γ-lyase; CoPP, cobalt protoporphyrin; ZnPP, zinc protoporphyrin IX.](etm-10-06-2039-g04){#f5-etm-0-0-2823}

###### 

Comparison of serum ALT, AST and TBIL among the groups.

  Group       ALT (U/l)                                                   AST (U/l)                                                    TBIL (mg/dl)
  ----------- ----------------------------------------------------------- ------------------------------------------------------------ ----------------------------------------------------------
  Sham        37.25±5.32                                                  172.61±7.32                                                  0.81±0.22
  Cirrhosis   96.43±8.02^[a](#tfn1-etm-0-0-2823){ref-type="table-fn"}^    287.58±10.49^[a](#tfn1-etm-0-0-2823){ref-type="table-fn"}^   11.85±1.87^[a](#tfn1-etm-0-0-2823){ref-type="table-fn"}^
  CoPP        120.33±9.83^[b](#tfn2-etm-0-0-2823){ref-type="table-fn"}^   410.51±12.53^[b](#tfn2-etm-0-0-2823){ref-type="table-fn"}^   14.65±2.26^[b](#tfn2-etm-0-0-2823){ref-type="table-fn"}^
  ZnPP        45.42±5.59^[b](#tfn2-etm-0-0-2823){ref-type="table-fn"}^    205.08±8.03^[b](#tfn2-etm-0-0-2823){ref-type="table-fn"}^    5.59±2.24^[b](#tfn2-etm-0-0-2823){ref-type="table-fn"}^

P\<0.05 vs. sham group;

P\<0.05 vs. cirrhosis group. ALT, alanine aminotransferase; AST, aspartate aminotransferase; TBIL, total bilirubin; CoPP, cobalt protoporphyrin; ZnPP, zinc protoporphyrin IX.

###### 

PVP and concentrations of endogenous H~2~S and COHb among the groups.

  Group       H~2~S (µmol/l)                                               COHb (%)                                                  PVP (cmH~2~O)
  ----------- ------------------------------------------------------------ --------------------------------------------------------- ----------------------------------------------------------
  Sham        369.54±51.28                                                 0.23±0.05                                                 9.05±0.53
  Cirrhosis   142.85±38.58^[a](#tfn3-etm-0-0-2823){ref-type="table-fn"}^   0.50±0.20^[a](#tfn3-etm-0-0-2823){ref-type="table-fn"}^   14.87±2.02^[a](#tfn3-etm-0-0-2823){ref-type="table-fn"}^
  CoPP        109.23±27.32^[b](#tfn4-etm-0-0-2823){ref-type="table-fn"}^   0.83±0.39^[b](#tfn4-etm-0-0-2823){ref-type="table-fn"}^   17.58±1.23^[b](#tfn4-etm-0-0-2823){ref-type="table-fn"}^
  ZnPP        215.38±33.56^[b](#tfn4-etm-0-0-2823){ref-type="table-fn"}^   0.23±0.06^[b](#tfn4-etm-0-0-2823){ref-type="table-fn"}^   13.21±1.14^[b](#tfn4-etm-0-0-2823){ref-type="table-fn"}^

P\<0.05 vs. sham group;

P\<0.05 vs. cirrhosis group. COHb, carboxyhemoglobin; PVP, portal vein pressure; CoPP, cobalt protoporphyrin; ZnPP, zinc protoporphyrin IX.
